tiprankstipranks
Trending News
More News >
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
US Market
Advertisement

Neuphoria Therapeutics (NEUP) Ratios

Compare
251 Followers

Neuphoria Therapeutics Ratios

NEUP's free cash flow for Q3 2024 was $0.99. For the 2024 fiscal year, NEUP's free cash flow was decreased by $ and operating cash flow was $0.75. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio
11.01 12.46 13.10 1.01
Quick Ratio
11.01 12.46 13.10 1.01
Cash Ratio
10.98 10.00 12.07 0.55
Solvency Ratio
1.36 -2.46 -1.05 -0.21
Operating Cash Flow Ratio
0.27 -6.48 -3.19 -0.47
Short-Term Operating Cash Flow Coverage
2.72 0.00 0.00 -0.75
Net Current Asset Value
$ 12.37M$ 22.99M$ 18.23M$ -9.24M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.01 0.02 0.36
Debt-to-Equity Ratio
<0.01 0.01 0.02 0.96
Debt-to-Capital Ratio
<0.01 0.01 0.02 0.49
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.33
Financial Leverage Ratio
1.18 1.15 1.14 2.72
Debt Service Coverage Ratio
32.21 -767.48 -4.96 -0.23
Interest Coverage Ratio
0.00 -794.21 -10.15 -5.02
Debt to Market Cap
0.01 0.00 0.00 <0.01
Interest Debt Per Share
<0.01 <0.01 0.02 0.21
Net Debt to EBITDA
-3.55 1.58 4.60 -4.28
Profitability Margins
Gross Profit Margin
96.83%100.00%0.00%100.00%
EBIT Margin
26.08%-8316.20%0.00%-9070.16%
EBITDA Margin
30.31%-7895.38%0.00%-3833.74%
Operating Profit Margin
14.76%-8095.15%0.00%-19319.28%
Pretax Profit Margin
35.44%-8326.39%0.00%-12915.56%
Net Profit Margin
36.62%-8253.64%0.00%-15255.19%
Continuous Operations Profit Margin
36.62%-8253.64%0.00%-12470.63%
Net Income Per EBT
103.34%99.13%97.89%118.11%
EBT Per EBIT
240.12%102.86%74.52%66.85%
Return on Assets (ROA)
18.67%-33.32%-16.03%-20.65%
Return on Equity (ROE)
30.88%-38.23%-18.27%-56.13%
Return on Capital Employed (ROCE)
7.93%-34.45%-22.97%-34.42%
Return on Invested Capital (ROIC)
8.11%-34.06%-22.41%-27.08%
Return on Tangible Assets
33.17%-51.07%-27.25%-72.46%
Earnings Yield
0.32%-0.16%-0.04%-0.04%
Efficiency Ratios
Receivables Turnover
636.90 0.04 0.00 0.79
Payables Turnover
0.67 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00
Fixed Asset Turnover
123.49 0.39 0.00 0.04
Asset Turnover
0.51 <0.01 0.00 <0.01
Working Capital Turnover Ratio
1.76 <0.01 0.00 <0.01
Cash Conversion Cycle
-546.98 9.39K 0.00 463.78
Days of Sales Outstanding
0.57 9.39K 0.00 463.78
Days of Inventory Outstanding
0.00 0.00 0.00 0.00
Days of Payables Outstanding
547.55 0.00 0.00 0.00
Operating Cycle
0.57 9.39K 0.00 463.78
Cash Flow Ratios
Operating Cash Flow Per Share
<0.01 -0.13 -0.09 -0.06
Free Cash Flow Per Share
<0.01 -0.13 -0.09 -0.06
CapEx Per Share
<0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
139.06K -14.09K -5.14K -506.64
Capital Expenditure Coverage Ratio
139.06K -14.09K -5.14K -506.64
Operating Cash Flow Coverage Ratio
2.42 -31.37 -8.69 -0.32
Operating Cash Flow to Sales Ratio
0.03 -82.52 0.00 -83.65
Free Cash Flow Yield
2.92%-0.16%-0.04%-0.02%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
309.67 -631.99 -2.34K -2.38K
Price-to-Sales (P/S) Ratio
0.91 52.16K 0.00 362.59K
Price-to-Book (P/B) Ratio
68.32 241.63 428.20 1.33K
Price-to-Free Cash Flow (P/FCF) Ratio
34.20 -632.06 -2.70K -4.33K
Price-to-Operating Cash Flow Ratio
4.26K -632.10 -2.70K -4.33K
Price-to-Earnings Growth (PEG) Ratio
2.45 -20.54 124.98 87.15
Price-to-Fair Value
68.32 241.63 428.20 1.33K
Enterprise Value Multiple
-0.55 -659.09 -3.39K -9.46K
Enterprise Value
-2.60M 9.44B 15.29B 11.63B
EV to EBITDA
-0.55 -659.09 -3.39K -9.46K
EV to Sales
-0.17 52.04K 0.00 362.75K
EV to Free Cash Flow
-6.24 -630.55 -2.70K -4.33K
EV to Operating Cash Flow
-6.24 -630.59 -2.70K -4.34K
Tangible Book Value Per Share
0.05 0.21 0.29 -0.18
Shareholders’ Equity Per Share
0.11 0.35 0.55 0.19
Tax and Other Ratios
Effective Tax Rate
-0.03 <0.01 0.02 0.03
Revenue Per Share
0.07 <0.01 0.00 <0.01
Net Income Per Share
0.02 -0.13 -0.10 -0.11
Tax Burden
1.03 0.99 0.98 1.18
Interest Burden
1.36 1.00 1.15 1.42
Research & Development to Revenue
0.41 60.69 0.00 124.90
SG&A to Revenue
0.27 29.06 0.00 103.96
Stock-Based Compensation to Revenue
0.01 10.73 0.00 1.19
Income Quality
0.07 1.00 0.87 0.55
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis